Dr. J. Jacques Carter Joins OncBioMune Pharmaceuticals Scientific Advisory Board


March 24, 2016 Facebook Twitter LinkedIn Google+ Press Releases


BATON ROUGE, LA–(Marketwired – March 22, 2016) – OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (“OncBioMune” or the “Company”), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce the appointment of Dr. J. Jacques Carter to the Company’s Scientific Advisory Board.

Read More…

Marketwired – Pharmaceuticals and Biotech

Comments